nodes	percent_of_prediction	percent_of_DWPC	metapath
Budesonide—Dexamethasone—NR0B1—germ cell cancer	0.0142	1	CrCbGaD
Budesonide—CYP3A4—Ifosfamide—germ cell cancer	0.0109	0.498	CbGbCtD
Budesonide—CYP3A4—Vinblastine—germ cell cancer	0.00577	0.264	CbGbCtD
Budesonide—CYP3A4—Etoposide—germ cell cancer	0.0052	0.238	CbGbCtD
Budesonide—Vision blurred—Ifosfamide—germ cell cancer	0.00253	0.00262	CcSEcCtD
Budesonide—Feeling abnormal—Vinblastine—germ cell cancer	0.0025	0.00259	CcSEcCtD
Budesonide—Myalgia—Dactinomycin—germ cell cancer	0.00249	0.00258	CcSEcCtD
Budesonide—Ill-defined disorder—Ifosfamide—germ cell cancer	0.00249	0.00258	CcSEcCtD
Budesonide—Eye disorder—Cisplatin—germ cell cancer	0.00248	0.00257	CcSEcCtD
Budesonide—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00248	0.00257	CcSEcCtD
Budesonide—Anaemia—Ifosfamide—germ cell cancer	0.00248	0.00257	CcSEcCtD
Budesonide—Lymphadenopathy—Methotrexate—germ cell cancer	0.00247	0.00256	CcSEcCtD
Budesonide—Flushing—Cisplatin—germ cell cancer	0.00246	0.00256	CcSEcCtD
Budesonide—Cardiac disorder—Cisplatin—germ cell cancer	0.00246	0.00256	CcSEcCtD
Budesonide—Agitation—Ifosfamide—germ cell cancer	0.00246	0.00256	CcSEcCtD
Budesonide—Discomfort—Dactinomycin—germ cell cancer	0.00246	0.00255	CcSEcCtD
Budesonide—Angioedema—Ifosfamide—germ cell cancer	0.00245	0.00254	CcSEcCtD
Budesonide—Anorexia—Bleomycin—germ cell cancer	0.00244	0.00253	CcSEcCtD
Budesonide—Malaise—Ifosfamide—germ cell cancer	0.00242	0.00251	CcSEcCtD
Budesonide—Vertigo—Ifosfamide—germ cell cancer	0.00241	0.0025	CcSEcCtD
Budesonide—Urinary tract disorder—Etoposide—germ cell cancer	0.0024	0.00249	CcSEcCtD
Budesonide—Immune system disorder—Cisplatin—germ cell cancer	0.0024	0.00249	CcSEcCtD
Budesonide—Abdominal pain—Vinblastine—germ cell cancer	0.0024	0.00249	CcSEcCtD
Budesonide—Mediastinal disorder—Cisplatin—germ cell cancer	0.00239	0.00248	CcSEcCtD
Budesonide—Urethral disorder—Etoposide—germ cell cancer	0.00238	0.00247	CcSEcCtD
Budesonide—Infection—Dactinomycin—germ cell cancer	0.00237	0.00246	CcSEcCtD
Budesonide—Palpitations—Ifosfamide—germ cell cancer	0.00237	0.00246	CcSEcCtD
Budesonide—Alopecia—Cisplatin—germ cell cancer	0.00235	0.00243	CcSEcCtD
Budesonide—Cough—Ifosfamide—germ cell cancer	0.00234	0.00243	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.00233	0.00242	CcSEcCtD
Budesonide—Hypertension—Ifosfamide—germ cell cancer	0.00231	0.0024	CcSEcCtD
Budesonide—Malnutrition—Cisplatin—germ cell cancer	0.00231	0.0024	CcSEcCtD
Budesonide—Paraesthesia—Bleomycin—germ cell cancer	0.0023	0.00238	CcSEcCtD
Budesonide—Dyspnoea—Bleomycin—germ cell cancer	0.00228	0.00237	CcSEcCtD
Budesonide—Arthralgia—Ifosfamide—germ cell cancer	0.00228	0.00237	CcSEcCtD
Budesonide—Chest pain—Ifosfamide—germ cell cancer	0.00228	0.00237	CcSEcCtD
Budesonide—Myalgia—Ifosfamide—germ cell cancer	0.00228	0.00237	CcSEcCtD
Budesonide—Flatulence—Cisplatin—germ cell cancer	0.00228	0.00236	CcSEcCtD
Budesonide—Anorexia—Dactinomycin—germ cell cancer	0.00228	0.00236	CcSEcCtD
Budesonide—Eye disorder—Etoposide—germ cell cancer	0.00227	0.00236	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.00227	0.00235	CcSEcCtD
Budesonide—Flushing—Etoposide—germ cell cancer	0.00226	0.00234	CcSEcCtD
Budesonide—Cardiac disorder—Etoposide—germ cell cancer	0.00226	0.00234	CcSEcCtD
Budesonide—Discomfort—Ifosfamide—germ cell cancer	0.00225	0.00234	CcSEcCtD
Budesonide—Hypersensitivity—Vinblastine—germ cell cancer	0.00223	0.00232	CcSEcCtD
Budesonide—Decreased appetite—Bleomycin—germ cell cancer	0.00223	0.00231	CcSEcCtD
Budesonide—Muscle spasms—Cisplatin—germ cell cancer	0.00222	0.0023	CcSEcCtD
Budesonide—Angiopathy—Etoposide—germ cell cancer	0.00221	0.00229	CcSEcCtD
Budesonide—Confusional state—Ifosfamide—germ cell cancer	0.00221	0.00229	CcSEcCtD
Budesonide—Immune system disorder—Etoposide—germ cell cancer	0.0022	0.00228	CcSEcCtD
Budesonide—Mediastinal disorder—Etoposide—germ cell cancer	0.00219	0.00227	CcSEcCtD
Budesonide—Pain—Bleomycin—germ cell cancer	0.00219	0.00227	CcSEcCtD
Budesonide—Anaphylactic shock—Ifosfamide—germ cell cancer	0.00219	0.00227	CcSEcCtD
Budesonide—Vision blurred—Cisplatin—germ cell cancer	0.00218	0.00226	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00217	0.00226	CcSEcCtD
Budesonide—Asthenia—Vinblastine—germ cell cancer	0.00217	0.00226	CcSEcCtD
Budesonide—Infection—Ifosfamide—germ cell cancer	0.00217	0.00225	CcSEcCtD
Budesonide—Tremor—Cisplatin—germ cell cancer	0.00217	0.00225	CcSEcCtD
Budesonide—Alopecia—Etoposide—germ cell cancer	0.00215	0.00223	CcSEcCtD
Budesonide—Nervous system disorder—Ifosfamide—germ cell cancer	0.00215	0.00223	CcSEcCtD
Budesonide—Ill-defined disorder—Cisplatin—germ cell cancer	0.00214	0.00222	CcSEcCtD
Budesonide—Anaemia—Cisplatin—germ cell cancer	0.00214	0.00222	CcSEcCtD
Budesonide—Skin disorder—Ifosfamide—germ cell cancer	0.00212	0.0022	CcSEcCtD
Budesonide—Hyperhidrosis—Ifosfamide—germ cell cancer	0.00211	0.00219	CcSEcCtD
Budesonide—Feeling abnormal—Bleomycin—germ cell cancer	0.00211	0.00219	CcSEcCtD
Budesonide—Anorexia—Ifosfamide—germ cell cancer	0.00209	0.00216	CcSEcCtD
Budesonide—Malaise—Cisplatin—germ cell cancer	0.00208	0.00216	CcSEcCtD
Budesonide—Decreased appetite—Dactinomycin—germ cell cancer	0.00208	0.00215	CcSEcCtD
Budesonide—Diarrhoea—Vinblastine—germ cell cancer	0.00207	0.00215	CcSEcCtD
Budesonide—Dysgeusia—Etoposide—germ cell cancer	0.00207	0.00215	CcSEcCtD
Budesonide—Fatigue—Dactinomycin—germ cell cancer	0.00206	0.00214	CcSEcCtD
Budesonide—Back pain—Etoposide—germ cell cancer	0.00205	0.00212	CcSEcCtD
Budesonide—Pain—Dactinomycin—germ cell cancer	0.00204	0.00212	CcSEcCtD
Budesonide—Muscle spasms—Etoposide—germ cell cancer	0.00204	0.00211	CcSEcCtD
Budesonide—Urticaria—Bleomycin—germ cell cancer	0.00203	0.00211	CcSEcCtD
Budesonide—Body temperature increased—Bleomycin—germ cell cancer	0.00202	0.0021	CcSEcCtD
Budesonide—Irritability—Methotrexate—germ cell cancer	0.00201	0.00208	CcSEcCtD
Budesonide—Dizziness—Vinblastine—germ cell cancer	0.002	0.00208	CcSEcCtD
Budesonide—Mood swings—Methotrexate—germ cell cancer	0.00199	0.00207	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.00199	0.00207	CcSEcCtD
Budesonide—Myalgia—Cisplatin—germ cell cancer	0.00197	0.00204	CcSEcCtD
Budesonide—Feeling abnormal—Dactinomycin—germ cell cancer	0.00197	0.00204	CcSEcCtD
Budesonide—Paraesthesia—Ifosfamide—germ cell cancer	0.00196	0.00204	CcSEcCtD
Budesonide—Ill-defined disorder—Etoposide—germ cell cancer	0.00196	0.00204	CcSEcCtD
Budesonide—Anxiety—Cisplatin—germ cell cancer	0.00196	0.00203	CcSEcCtD
Budesonide—Anaemia—Etoposide—germ cell cancer	0.00196	0.00203	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00195	0.00203	CcSEcCtD
Budesonide—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.00195	0.00203	CcSEcCtD
Budesonide—Dyspnoea—Ifosfamide—germ cell cancer	0.00195	0.00202	CcSEcCtD
Budesonide—Somnolence—Ifosfamide—germ cell cancer	0.00194	0.00202	CcSEcCtD
Budesonide—Discomfort—Cisplatin—germ cell cancer	0.00194	0.00202	CcSEcCtD
Budesonide—Vomiting—Vinblastine—germ cell cancer	0.00193	0.002	CcSEcCtD
Budesonide—Malaise—Etoposide—germ cell cancer	0.00191	0.00198	CcSEcCtD
Budesonide—Breast disorder—Methotrexate—germ cell cancer	0.0019	0.00197	CcSEcCtD
Budesonide—Vertigo—Etoposide—germ cell cancer	0.0019	0.00197	CcSEcCtD
Budesonide—Decreased appetite—Ifosfamide—germ cell cancer	0.0019	0.00197	CcSEcCtD
Budesonide—Headache—Vinblastine—germ cell cancer	0.0019	0.00197	CcSEcCtD
Budesonide—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.00189	0.00196	CcSEcCtD
Budesonide—Abdominal pain—Dactinomycin—germ cell cancer	0.00189	0.00196	CcSEcCtD
Budesonide—Body temperature increased—Dactinomycin—germ cell cancer	0.00189	0.00196	CcSEcCtD
Budesonide—Fatigue—Ifosfamide—germ cell cancer	0.00189	0.00196	CcSEcCtD
Budesonide—Anaphylactic shock—Cisplatin—germ cell cancer	0.00189	0.00196	CcSEcCtD
Budesonide—Hypersensitivity—Bleomycin—germ cell cancer	0.00189	0.00196	CcSEcCtD
Budesonide—Infection—Cisplatin—germ cell cancer	0.00187	0.00194	CcSEcCtD
Budesonide—Constipation—Ifosfamide—germ cell cancer	0.00187	0.00194	CcSEcCtD
Budesonide—Pain—Ifosfamide—germ cell cancer	0.00187	0.00194	CcSEcCtD
Budesonide—Loss of consciousness—Etoposide—germ cell cancer	0.00186	0.00193	CcSEcCtD
Budesonide—Nervous system disorder—Cisplatin—germ cell cancer	0.00185	0.00192	CcSEcCtD
Budesonide—Cough—Etoposide—germ cell cancer	0.00185	0.00192	CcSEcCtD
Budesonide—Tachycardia—Cisplatin—germ cell cancer	0.00184	0.00191	CcSEcCtD
Budesonide—Asthenia—Bleomycin—germ cell cancer	0.00184	0.00191	CcSEcCtD
Budesonide—Skin disorder—Cisplatin—germ cell cancer	0.00183	0.0019	CcSEcCtD
Budesonide—Hypertension—Etoposide—germ cell cancer	0.00183	0.0019	CcSEcCtD
Budesonide—Hyperhidrosis—Cisplatin—germ cell cancer	0.00182	0.00189	CcSEcCtD
Budesonide—Pruritus—Bleomycin—germ cell cancer	0.00181	0.00188	CcSEcCtD
Budesonide—Feeling abnormal—Ifosfamide—germ cell cancer	0.0018	0.00187	CcSEcCtD
Budesonide—Chest pain—Etoposide—germ cell cancer	0.0018	0.00187	CcSEcCtD
Budesonide—Nausea—Vinblastine—germ cell cancer	0.0018	0.00187	CcSEcCtD
Budesonide—Anorexia—Cisplatin—germ cell cancer	0.0018	0.00186	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.00179	0.00186	CcSEcCtD
Budesonide—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.00179	0.00186	CcSEcCtD
Budesonide—Discomfort—Etoposide—germ cell cancer	0.00178	0.00185	CcSEcCtD
Budesonide—Hypersensitivity—Dactinomycin—germ cell cancer	0.00176	0.00182	CcSEcCtD
Budesonide—Confusional state—Etoposide—germ cell cancer	0.00174	0.00181	CcSEcCtD
Budesonide—Urticaria—Ifosfamide—germ cell cancer	0.00174	0.0018	CcSEcCtD
Budesonide—Body temperature increased—Ifosfamide—germ cell cancer	0.00173	0.00179	CcSEcCtD
Budesonide—Abdominal pain—Ifosfamide—germ cell cancer	0.00173	0.00179	CcSEcCtD
Budesonide—Anaphylactic shock—Etoposide—germ cell cancer	0.00173	0.00179	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.00172	0.00178	CcSEcCtD
Budesonide—Infection—Etoposide—germ cell cancer	0.00172	0.00178	CcSEcCtD
Budesonide—Asthenia—Dactinomycin—germ cell cancer	0.00171	0.00178	CcSEcCtD
Budesonide—Dysuria—Methotrexate—germ cell cancer	0.0017	0.00177	CcSEcCtD
Budesonide—Paraesthesia—Cisplatin—germ cell cancer	0.00169	0.00176	CcSEcCtD
Budesonide—Tachycardia—Etoposide—germ cell cancer	0.00169	0.00175	CcSEcCtD
Budesonide—Dyspnoea—Cisplatin—germ cell cancer	0.00168	0.00174	CcSEcCtD
Budesonide—Skin disorder—Etoposide—germ cell cancer	0.00168	0.00174	CcSEcCtD
Budesonide—Hyperhidrosis—Etoposide—germ cell cancer	0.00167	0.00173	CcSEcCtD
Budesonide—Anorexia—Etoposide—germ cell cancer	0.00165	0.00171	CcSEcCtD
Budesonide—Decreased appetite—Cisplatin—germ cell cancer	0.00164	0.0017	CcSEcCtD
Budesonide—Diarrhoea—Dactinomycin—germ cell cancer	0.00163	0.00169	CcSEcCtD
Budesonide—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00163	0.00169	CcSEcCtD
Budesonide—Vomiting—Bleomycin—germ cell cancer	0.00163	0.00169	CcSEcCtD
Budesonide—Infestation NOS—Methotrexate—germ cell cancer	0.00162	0.00168	CcSEcCtD
Budesonide—Infestation—Methotrexate—germ cell cancer	0.00162	0.00168	CcSEcCtD
Budesonide—Rash—Bleomycin—germ cell cancer	0.00161	0.00167	CcSEcCtD
Budesonide—Pain—Cisplatin—germ cell cancer	0.00161	0.00167	CcSEcCtD
Budesonide—Dermatitis—Bleomycin—germ cell cancer	0.00161	0.00167	CcSEcCtD
Budesonide—Hypersensitivity—Ifosfamide—germ cell cancer	0.00161	0.00167	CcSEcCtD
Budesonide—Conjunctivitis—Methotrexate—germ cell cancer	0.00158	0.00164	CcSEcCtD
Budesonide—Asthenia—Ifosfamide—germ cell cancer	0.00157	0.00163	CcSEcCtD
Budesonide—Feeling abnormal—Cisplatin—germ cell cancer	0.00155	0.00161	CcSEcCtD
Budesonide—Paraesthesia—Etoposide—germ cell cancer	0.00155	0.00161	CcSEcCtD
Budesonide—Pruritus—Ifosfamide—germ cell cancer	0.00155	0.00161	CcSEcCtD
Budesonide—Haematuria—Methotrexate—germ cell cancer	0.00155	0.00161	CcSEcCtD
Budesonide—Dyspnoea—Etoposide—germ cell cancer	0.00154	0.0016	CcSEcCtD
Budesonide—Somnolence—Etoposide—germ cell cancer	0.00154	0.00159	CcSEcCtD
Budesonide—Epistaxis—Methotrexate—germ cell cancer	0.00153	0.00159	CcSEcCtD
Budesonide—Nausea—Bleomycin—germ cell cancer	0.00152	0.00158	CcSEcCtD
Budesonide—Vomiting—Dactinomycin—germ cell cancer	0.00152	0.00157	CcSEcCtD
Budesonide—Rash—Dactinomycin—germ cell cancer	0.00151	0.00156	CcSEcCtD
Budesonide—Decreased appetite—Etoposide—germ cell cancer	0.0015	0.00156	CcSEcCtD
Budesonide—Diarrhoea—Ifosfamide—germ cell cancer	0.0015	0.00155	CcSEcCtD
Budesonide—Gastrointestinal disorder—Etoposide—germ cell cancer	0.00149	0.00155	CcSEcCtD
Budesonide—Body temperature increased—Cisplatin—germ cell cancer	0.00149	0.00155	CcSEcCtD
Budesonide—Fatigue—Etoposide—germ cell cancer	0.00149	0.00155	CcSEcCtD
Budesonide—Pain—Etoposide—germ cell cancer	0.00148	0.00153	CcSEcCtD
Budesonide—Constipation—Etoposide—germ cell cancer	0.00148	0.00153	CcSEcCtD
Budesonide—Haemoglobin—Methotrexate—germ cell cancer	0.00146	0.00152	CcSEcCtD
Budesonide—Haemorrhage—Methotrexate—germ cell cancer	0.00146	0.00151	CcSEcCtD
Budesonide—Dizziness—Ifosfamide—germ cell cancer	0.00145	0.0015	CcSEcCtD
Budesonide—Pharyngitis—Methotrexate—germ cell cancer	0.00145	0.0015	CcSEcCtD
Budesonide—Urinary tract disorder—Methotrexate—germ cell cancer	0.00144	0.00149	CcSEcCtD
Budesonide—Urethral disorder—Methotrexate—germ cell cancer	0.00143	0.00148	CcSEcCtD
Budesonide—Feeling abnormal—Etoposide—germ cell cancer	0.00142	0.00148	CcSEcCtD
Budesonide—Nausea—Dactinomycin—germ cell cancer	0.00142	0.00147	CcSEcCtD
Budesonide—Gastrointestinal pain—Etoposide—germ cell cancer	0.00141	0.00147	CcSEcCtD
Budesonide—Visual impairment—Methotrexate—germ cell cancer	0.0014	0.00146	CcSEcCtD
Budesonide—Vomiting—Ifosfamide—germ cell cancer	0.00139	0.00144	CcSEcCtD
Budesonide—Hypersensitivity—Cisplatin—germ cell cancer	0.00139	0.00144	CcSEcCtD
Budesonide—Rash—Ifosfamide—germ cell cancer	0.00138	0.00143	CcSEcCtD
Budesonide—Dermatitis—Ifosfamide—germ cell cancer	0.00138	0.00143	CcSEcCtD
Budesonide—Urticaria—Etoposide—germ cell cancer	0.00137	0.00142	CcSEcCtD
Budesonide—Body temperature increased—Etoposide—germ cell cancer	0.00137	0.00142	CcSEcCtD
Budesonide—Abdominal pain—Etoposide—germ cell cancer	0.00137	0.00142	CcSEcCtD
Budesonide—Eye disorder—Methotrexate—germ cell cancer	0.00136	0.00141	CcSEcCtD
Budesonide—Asthenia—Cisplatin—germ cell cancer	0.00135	0.0014	CcSEcCtD
Budesonide—Cardiac disorder—Methotrexate—germ cell cancer	0.00135	0.0014	CcSEcCtD
Budesonide—Angiopathy—Methotrexate—germ cell cancer	0.00132	0.00137	CcSEcCtD
Budesonide—Immune system disorder—Methotrexate—germ cell cancer	0.00132	0.00136	CcSEcCtD
Budesonide—Mediastinal disorder—Methotrexate—germ cell cancer	0.00131	0.00136	CcSEcCtD
Budesonide—Nausea—Ifosfamide—germ cell cancer	0.0013	0.00135	CcSEcCtD
Budesonide—Diarrhoea—Cisplatin—germ cell cancer	0.00129	0.00134	CcSEcCtD
Budesonide—Alopecia—Methotrexate—germ cell cancer	0.00129	0.00134	CcSEcCtD
Budesonide—Mental disorder—Methotrexate—germ cell cancer	0.00128	0.00132	CcSEcCtD
Budesonide—Hypersensitivity—Etoposide—germ cell cancer	0.00127	0.00132	CcSEcCtD
Budesonide—Malnutrition—Methotrexate—germ cell cancer	0.00127	0.00132	CcSEcCtD
Budesonide—Dysgeusia—Methotrexate—germ cell cancer	0.00124	0.00129	CcSEcCtD
Budesonide—Asthenia—Etoposide—germ cell cancer	0.00124	0.00129	CcSEcCtD
Budesonide—Back pain—Methotrexate—germ cell cancer	0.00123	0.00127	CcSEcCtD
Budesonide—Pruritus—Etoposide—germ cell cancer	0.00122	0.00127	CcSEcCtD
Budesonide—Vomiting—Cisplatin—germ cell cancer	0.0012	0.00124	CcSEcCtD
Budesonide—Vision blurred—Methotrexate—germ cell cancer	0.0012	0.00124	CcSEcCtD
Budesonide—Rash—Cisplatin—germ cell cancer	0.00119	0.00123	CcSEcCtD
Budesonide—Dermatitis—Cisplatin—germ cell cancer	0.00119	0.00123	CcSEcCtD
Budesonide—Diarrhoea—Etoposide—germ cell cancer	0.00118	0.00123	CcSEcCtD
Budesonide—Ill-defined disorder—Methotrexate—germ cell cancer	0.00118	0.00122	CcSEcCtD
Budesonide—Anaemia—Methotrexate—germ cell cancer	0.00117	0.00122	CcSEcCtD
Budesonide—Malaise—Methotrexate—germ cell cancer	0.00114	0.00119	CcSEcCtD
Budesonide—Dizziness—Etoposide—germ cell cancer	0.00114	0.00119	CcSEcCtD
Budesonide—Vertigo—Methotrexate—germ cell cancer	0.00114	0.00118	CcSEcCtD
Budesonide—Nausea—Cisplatin—germ cell cancer	0.00112	0.00116	CcSEcCtD
Budesonide—Cough—Methotrexate—germ cell cancer	0.00111	0.00115	CcSEcCtD
Budesonide—Vomiting—Etoposide—germ cell cancer	0.0011	0.00114	CcSEcCtD
Budesonide—Rash—Etoposide—germ cell cancer	0.00109	0.00113	CcSEcCtD
Budesonide—Dermatitis—Etoposide—germ cell cancer	0.00109	0.00113	CcSEcCtD
Budesonide—Headache—Etoposide—germ cell cancer	0.00108	0.00112	CcSEcCtD
Budesonide—Arthralgia—Methotrexate—germ cell cancer	0.00108	0.00112	CcSEcCtD
Budesonide—Myalgia—Methotrexate—germ cell cancer	0.00108	0.00112	CcSEcCtD
Budesonide—Chest pain—Methotrexate—germ cell cancer	0.00108	0.00112	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.00107	0.00111	CcSEcCtD
Budesonide—Discomfort—Methotrexate—germ cell cancer	0.00107	0.00111	CcSEcCtD
Budesonide—Confusional state—Methotrexate—germ cell cancer	0.00104	0.00108	CcSEcCtD
Budesonide—Anaphylactic shock—Methotrexate—germ cell cancer	0.00103	0.00107	CcSEcCtD
Budesonide—Infection—Methotrexate—germ cell cancer	0.00103	0.00107	CcSEcCtD
Budesonide—Nausea—Etoposide—germ cell cancer	0.00103	0.00106	CcSEcCtD
Budesonide—Nervous system disorder—Methotrexate—germ cell cancer	0.00101	0.00105	CcSEcCtD
Budesonide—Skin disorder—Methotrexate—germ cell cancer	0.00101	0.00104	CcSEcCtD
Budesonide—Hyperhidrosis—Methotrexate—germ cell cancer	0.001	0.00104	CcSEcCtD
Budesonide—Anorexia—Methotrexate—germ cell cancer	0.000987	0.00102	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000943	0.000978	CcSEcCtD
Budesonide—Insomnia—Methotrexate—germ cell cancer	0.000936	0.000971	CcSEcCtD
Budesonide—Paraesthesia—Methotrexate—germ cell cancer	0.000929	0.000964	CcSEcCtD
Budesonide—Dyspnoea—Methotrexate—germ cell cancer	0.000923	0.000957	CcSEcCtD
Budesonide—Somnolence—Methotrexate—germ cell cancer	0.00092	0.000954	CcSEcCtD
Budesonide—Dyspepsia—Methotrexate—germ cell cancer	0.000911	0.000945	CcSEcCtD
Budesonide—Decreased appetite—Methotrexate—germ cell cancer	0.0009	0.000933	CcSEcCtD
Budesonide—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000893	0.000927	CcSEcCtD
Budesonide—Fatigue—Methotrexate—germ cell cancer	0.000892	0.000926	CcSEcCtD
Budesonide—Pain—Methotrexate—germ cell cancer	0.000885	0.000918	CcSEcCtD
Budesonide—Feeling abnormal—Methotrexate—germ cell cancer	0.000853	0.000885	CcSEcCtD
Budesonide—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000846	0.000878	CcSEcCtD
Budesonide—Urticaria—Methotrexate—germ cell cancer	0.000822	0.000853	CcSEcCtD
Budesonide—Abdominal pain—Methotrexate—germ cell cancer	0.000818	0.000849	CcSEcCtD
Budesonide—Body temperature increased—Methotrexate—germ cell cancer	0.000818	0.000849	CcSEcCtD
Budesonide—Hypersensitivity—Methotrexate—germ cell cancer	0.000762	0.000791	CcSEcCtD
Budesonide—Asthenia—Methotrexate—germ cell cancer	0.000743	0.00077	CcSEcCtD
Budesonide—Pruritus—Methotrexate—germ cell cancer	0.000732	0.00076	CcSEcCtD
Budesonide—Diarrhoea—Methotrexate—germ cell cancer	0.000708	0.000735	CcSEcCtD
Budesonide—Dizziness—Methotrexate—germ cell cancer	0.000684	0.00071	CcSEcCtD
Budesonide—Vomiting—Methotrexate—germ cell cancer	0.000658	0.000683	CcSEcCtD
Budesonide—Rash—Methotrexate—germ cell cancer	0.000653	0.000677	CcSEcCtD
Budesonide—Dermatitis—Methotrexate—germ cell cancer	0.000652	0.000676	CcSEcCtD
Budesonide—Headache—Methotrexate—germ cell cancer	0.000648	0.000673	CcSEcCtD
Budesonide—Nausea—Methotrexate—germ cell cancer	0.000615	0.000638	CcSEcCtD
